Mismatch repair gene mutations in renal cell carcinoma
Fredrick S Leach1, Moon Koh, Kirti Sharma
1Urologic Oncology Branch/NCI, National Institutes of Health, 10 Center Drive, Bldg.10/Room 2B47, Bethesda, MD 20892-1501, USA. leachf@mail.nih.gov
Abstract:
We investigated the spectrum and genetic basis for mismatch repair (MMR) deficiency in renal cell carcinoma (RCC) by examining expression of four MMR genes important for hereditary and sporadic carcinogenesis. MMR deficiency was assessed using microsatellite instability (MSI) and genetic analyses of 25 cell lines derived from renal tumors. MMR gene alterations were detected using reverse transcription of RNA coupled with polymerase chain reaction (RT-PCR) and DNA sequencing. Three RCC lines with undetectable MLH1 were identified and investigated for MSI and inactivating mutations in the hMLH1 MMR gene. Genetic instability and hMLH1 mutations were identified in two RCC lines and their corresponding tumors. Genetic alterations affecting expression were limited to MLH1 since other MMR proteins (MSH2, MSH6 and PMS2) were detectable in our RCC lines. Complete inactivation of MMR is apparently uncommon in RCC and occurs predominantly through inactivating mutations in the hMLH1 gene.
Insights
Mismatch repair (MMR) deficiency is uncommon in renal cell carcinoma (RCC). When present, it primarily results from inactivating mutations in the hMLH1 gene, impacting DNA repair in kidney tumors.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Mismatch repair (MMR) deficiency is implicated in various cancers, influencing hereditary and sporadic carcinogenesis.
- Understanding MMR gene status in renal cell carcinoma (RCC) is crucial for comprehending kidney cancer development.
- Key MMR genes include MLH1, MSH2, MSH6, and PMS2, which maintain genomic stability.
Purpose of the Study:
- To investigate the spectrum and genetic basis of MMR deficiency in renal cell carcinoma (RCC).
- To determine the frequency and specific genetic alterations leading to MMR deficiency in kidney tumors.
- To identify the predominant MMR gene involved in RCC carcinogenesis.
Main Methods:
- Analysis of 25 renal cell carcinoma (RCC) cell lines for MMR deficiency.
- Assessment of microsatellite instability (MSI) as a marker for MMR deficiency.
- Genetic analysis including reverse transcription of RNA coupled with polymerase chain reaction (RT-PCR) and DNA sequencing of MMR genes (MLH1, MSH2, MSH6, PMS2).
Main Results:
- Three RCC cell lines exhibited undetectable MLH1 expression.
- Two of these cell lines and their corresponding tumors showed microsatellite instability (MSI) and inactivating mutations in the hMLH1 gene.
- Other MMR proteins (MSH2, MSH6, PMS2) were detectable in the analyzed RCC lines, indicating alterations were specific to MLH1.
Conclusions:
- Complete inactivation of the mismatch repair (MMR) system is infrequent in renal cell carcinoma (RCC).
- The primary mechanism for MMR deficiency in RCC involves inactivating mutations in the hMLH1 gene.
- These findings highlight the specific role of hMLH1 in the pathogenesis of a subset of kidney cancers.
Related Concept Videos
Mismatch Repair
Mismatch Repair
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Mutation, Gene Flow, and Genetic Drift
Overview of DNA Repair
Chemically...
Mutations
Viral Mutations


